Financhill
Sell
40

V Quote, Financials, Valuation and Earnings

Last price:
$321.18
Seasonality move :
2.89%
Day range:
$317.82 - $322.35
52-week range:
$299.00 - $375.51
Dividend yield:
0.79%
P/E ratio:
30.41x
P/S ratio:
15.14x
P/B ratio:
16.15x
Volume:
6.8M
Avg. volume:
8.6M
1-year change:
-8.43%
Market cap:
$617.3B
Revenue:
$40B
EPS (TTM):
$10.55
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $24.1B $29.3B $32.7B $35.9B $40B
Revenue Growth (YoY) 10.34% 21.59% 11.41% 10.02% 11.34%
 
Cost of Revenues $5.8B $6.6B $7.5B $8.1B $9.1B
Gross Profit $18.3B $22.7B $25.1B $27.9B $30.9B
Gross Profit Margin 76.05% 77.5% 77% 77.52% 77.31%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.1B $2.5B $2.7B $3.2B $3.6B
Other Inc / (Exp) $769M -$1B -$246M $500M --
Operating Expenses $2.5B $3B $3.1B $3.7B $4.1B
Operating Income $15.8B $19.8B $22B $24.2B $26.9B
 
Net Interest Expenses $513M $538M $644M $641M $589M
EBT. Incl. Unusual Items $16.1B $18.1B $21B $23.9B $24.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.8B $3.2B $3.8B $4.2B $4.1B
Net Income to Company $12.3B $15B $17.3B $19.7B $20.1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $12B $14.6B $17B $19.5B $19.9B
 
Basic EPS (Cont. Ops) $5.64 $7.02 $8.30 $9.77 $10.23
Diluted EPS (Cont. Ops) $5.49 $6.85 $8.15 $9.59 $10.10
Weighted Average Basic Share $2.1B $2.1B $2B $2B $1.9B
Weighted Average Diluted Share $2.2B $2.1B $2.1B $2B $2B
 
EBITDA $16.6B $20.6B $23B $25.2B $28.1B
EBIT $15.8B $19.8B $22B $24.2B $26.9B
 
Revenue (Reported) $24.1B $29.3B $32.7B $35.9B $40B
Operating Income (Reported) $15.8B $19.8B $22B $24.2B $26.9B
Operating Income (Adjusted) $15.8B $19.8B $22B $24.2B $26.9B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $7.1B $7.9B $8.6B $9.5B $10.9B
Revenue Growth (YoY) 24.13% 12.42% 8.8% 10.15% 14.63%
 
Cost of Revenues $1.5B $1.7B $1.9B $2.3B $2.3B
Gross Profit $5.5B $6.2B $6.7B $7.2B $8.6B
Gross Profit Margin 78.57% 78.05% 77.91% 75.79% 78.69%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $242M $654M $633M $787M $925M
Other Inc / (Exp) $107M -$317M $266M $104M --
Operating Expenses $612M $740M $743M $683M $1.1B
Operating Income $4.9B $5.5B $6B $6.5B $7.5B
 
Net Interest Expenses $134M $137M $187M $182M $194M
EBT. Incl. Unusual Items $4.9B $5B $6B $6.2B $6.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $938M $798M $1.2B $1.1B $873M
Net Income to Company $4B $4.2B $4.9B $5.1B $5.9B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.9B $4.1B $4.8B $5.1B $5.8B
 
Basic EPS (Cont. Ops) $1.84 $1.99 $2.40 $2.58 $3.04
Diluted EPS (Cont. Ops) $1.79 $1.95 $2.36 $2.55 $3.00
Weighted Average Basic Share $2.1B $2.1B $2B $2B $1.9B
Weighted Average Diluted Share $2.2B $2.1B $2B $2B $1.9B
 
EBITDA $5.1B $5.7B $6.2B $6.8B $7.8B
EBIT $4.9B $5.5B $6B $6.5B $7.5B
 
Revenue (Reported) $7.1B $7.9B $8.6B $9.5B $10.9B
Operating Income (Reported) $4.9B $5.5B $6B $6.5B $7.5B
Operating Income (Adjusted) $4.9B $5.5B $6B $6.5B $7.5B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $25.5B $30.2B $33.4B $36.8B $41.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.9B $6.8B $7.7B $8.5B $9.1B
Gross Profit $19.5B $23.4B $25.7B $28.3B $32.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1B $2B $2.7B $3.3B $3.7B
Other Inc / (Exp) $837M -$1.4B $337M $338M --
Operating Expenses $2.6B $3.1B $3.1B $3.6B $4.5B
Operating Income $16.9B $20.3B $22.5B $24.7B $27.8B
 
Net Interest Expenses $511M $541M $694M $636M $601M
EBT. Incl. Unusual Items $17.2B $18.2B $22.1B $24.1B $24.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $4.1B $3B $4.1B $4.1B $3.9B
Net Income to Company $13.1B $15.2B $18B $20B $20.8B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $12.8B $14.9B $17.7B $19.7B $20.6B
 
Basic EPS (Cont. Ops) $6.05 $7.20 $8.70 $10.13 $10.68
Diluted EPS (Cont. Ops) $5.90 $7.01 $8.55 $9.79 $10.55
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $17.7B $21.2B $23.5B $25.8B $29.1B
EBIT $16.9B $20.3B $22.5B $24.7B $27.8B
 
Revenue (Reported) $25.5B $30.2B $33.4B $36.8B $41.4B
Operating Income (Reported) $16.9B $20.3B $22.5B $24.7B $27.8B
Operating Income (Adjusted) $16.9B $20.3B $22.5B $24.7B $27.8B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $7.1B $7.9B $8.6B $9.5B $10.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.5B $1.7B $1.9B $2.3B $2.3B
Gross Profit $5.5B $6.2B $6.7B $7.2B $8.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $242M $654M $633M $787M $925M
Other Inc / (Exp) $107M -$317M $266M $104M --
Operating Expenses $612M $740M $743M $683M $1.1B
Operating Income $4.9B $5.5B $6B $6.5B $7.5B
 
Net Interest Expenses $134M $137M $187M $182M $194M
EBT. Incl. Unusual Items $4.9B $5B $6B $6.2B $6.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $938M $798M $1.2B $1.1B $873M
Net Income to Company $4B $4.2B $4.9B $5.1B $5.9B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.9B $4.1B $4.8B $5.1B $5.8B
 
Basic EPS (Cont. Ops) $1.84 $1.99 $2.40 $2.58 $3.04
Diluted EPS (Cont. Ops) $1.79 $1.95 $2.36 $2.55 $3.00
Weighted Average Basic Share $2.1B $2.1B $2B $2B $1.9B
Weighted Average Diluted Share $2.2B $2.1B $2B $2B $1.9B
 
EBITDA $5.1B $5.7B $6.2B $6.8B $7.8B
EBIT $4.9B $5.5B $6B $6.5B $7.5B
 
Revenue (Reported) $7.1B $7.9B $8.6B $9.5B $10.9B
Operating Income (Reported) $4.9B $5.5B $6B $6.5B $7.5B
Operating Income (Adjusted) $4.9B $5.5B $6B $6.5B $7.5B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $19.6B $20.9B $22.8B $19.4B $23.2B
Short Term Investments $2B $2.8B $3.8B $3.2B --
Accounts Receivable, Net $2B $2B $2.3B $2.6B $3.1B
Inventory -- -- -- -- --
Prepaid Expenses $856M -- -- -- --
Other Current Assets $1.4B $3.9B $4.2B $5.2B --
Total Current Assets $27.6B $30.2B $33.5B $34B $37.8B
 
Property Plant And Equipment $2.7B $3.7B $3.9B $4.7B $5.2B
Long-Term Investments $3.2B $3.3B $3.3B $3.7B $2.1B
Goodwill $16B $17.8B $18B $18.9B --
Other Intangibles $27.7B $25.1B $26.1B $26.9B --
Other Long-Term Assets $7.2B $7.1B $7.5B $8.3B --
Total Assets $82.9B $85.5B $90.5B $94.5B $99.6B
 
Accounts Payable $266M $340M $375M $479M $555M
Accrued Expenses $3.3B $5.2B $6.8B $6.6B --
Current Portion Of Long-Term Debt $999M $2.3B -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $7.5B $8.4B $11.2B $12.6B --
Total Current Liabilities $15.7B $20.9B $23.1B $26.5B $35B
 
Long-Term Debt $20.5B $20.6B $20.9B $21.5B $20.4B
Capital Leases -- -- -- -- --
Total Liabilities $45.3B $49.9B $51.8B $55.4B $61.7B
 
Common Stock -- $2.3B $1.7B $1B --
Other Common Equity Adj -$257M $418M -$177M -$213M --
Common Equity $34.5B $33.3B $37B $38.1B $37.2B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $37.6B $35.6B $38.7B $39.1B $37.9B
 
Total Liabilities and Equity $82.9B $85.5B $90.5B $94.5B $99.6B
Cash and Short Terms $19.6B $20.9B $22.8B $19.4B $23.2B
Total Debt $21.5B $22.9B $20.9B $21.5B $25.9B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $17.2B $18.6B $21.5B $18.4B $21.1B
Short Term Investments $1.2B $2.8B $5B $2B --
Accounts Receivable, Net $2.2B $2.1B $2.5B $2.6B $3.2B
Inventory -- -- -- -- --
Prepaid Expenses $1.3B -- -- -- --
Other Current Assets $1.3B $3.2B $4.3B $5.4B --
Total Current Assets $25.9B $27.9B $32.7B $32.6B $35B
 
Property Plant And Equipment $2.9B $3.2B $3.5B $4B $4.3B
Long-Term Investments $2.6B $3.1B $3.2B $2.1B $912M
Goodwill $16.6B $18B $18.1B $19.5B --
Other Intangibles $27.3B $26.3B $26.7B $25.9B --
Other Long-Term Assets $7.2B $7.2B $7.5B $8.1B --
Total Assets $81.9B $85.4B $91.4B $91.9B $96.8B
 
Accounts Payable $252M $258M $348M $405M $433M
Accrued Expenses $4B $5.6B $6.5B $6.3B --
Current Portion Of Long-Term Debt $3.2B -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $7.6B $9.1B $11.2B $12.8B --
Total Current Liabilities $18.6B $19.4B $22.6B $29.1B $31.5B
 
Long-Term Debt $17.7B $20.5B $20.7B $16.7B $19.6B
Capital Leases -- -- -- -- --
Total Liabilities $45.7B $48.5B $51.7B $53.6B $58B
 
Common Stock -- $21.8B $22.1B $904M --
Other Common Equity Adj -$171M -$213M -$208M -$105M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $36.2B $36.9B $39.7B $38.3B $38.8B
 
Total Liabilities and Equity $81.9B $85.4B $91.4B $91.9B $96.8B
Cash and Short Terms $17.2B $18.6B $21.5B $18.4B $21.1B
Total Debt $20.9B $20.5B $20.7B $20.6B $21.2B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $12.3B $15B $17.3B $19.7B $20.1B
Depreciation & Amoritzation $804M $861M $943M $1B $1.2B
Stock-Based Compensation $542M $602M $765M $850M $897M
Change in Accounts Receivable -$811M -$494M -$410M -$2.4B -$168M
Change in Inventories -- -- -- -- --
Cash From Operations $15.2B $18.8B $20.8B $20B $23.1B
 
Capital Expenditures $705M $970M $1.1B $1.3B $1.5B
Cash Acquisitions $75M $1.9B -- $915M $887M
Cash From Investing -$152M -$4.3B -$2B -$1.9B $708M
 
Dividends Paid (Ex Special Dividend) $2.8B $3.2B $3.8B $4.2B $4.6B
Special Dividend Paid
Long-Term Debt Issued -- $3.2B -- -- --
Long-Term Debt Repaid -$3B -$1B -$2.3B -- --
Repurchase of Common Stock $8.7B $11.6B $12.1B $16.7B $18.3B
Other Financing Activities -$144M -$318M $70M -$38M --
Cash From Financing -$14.4B -$12.7B -$17.8B -$20.6B -$19B
 
Beginning Cash (CF) $17.5B $18B $19B $16.2B $21.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $628M $578M $1.6B -$2.2B $5.2B
Ending Cash (CF) $18.1B $17.3B $21.2B $14.4B $27B
 
Levered Free Cash Flow $14.5B $17.9B $19.7B $18.7B $21.6B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $4B $4.2B $4.9B $5.1B $5.9B
Depreciation & Amoritzation $198M $227M $247M $282M $326M
Stock-Based Compensation $128M $177M $209M $224M $231M
Change in Accounts Receivable -$289M -$114M -$452M $593M $872M
Change in Inventories -- -- -- -- --
Cash From Operations $4.2B $4.2B $3.6B $5.4B $6.8B
 
Capital Expenditures $173M $249M $267M $345M $378M
Cash Acquisitions $832M -- -- $906M --
Cash From Investing -$547M -$510M -$1.9B $790M $361M
 
Dividends Paid (Ex Special Dividend) $809M $945M $1.1B $1.2B $1.3B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -$2.3B -- -- --
Repurchase of Common Stock $4.1B $3.1B $3.6B $4B $3.7B
Other Financing Activities -- $19M $157M -$421M --
Cash From Financing -$5B -$6.3B -$4.4B -$5.5B -$9B
 
Beginning Cash (CF) $16B $15.8B $16.5B $16.4B $19.5B
Foreign Exchange Rate Adjustment -$194M $692M $300M -$508M $34M
Additions / Reductions -$1.5B -$2B -$2.4B $203M -$1.8B
Ending Cash (CF) $14.4B $14.5B $14.4B $16.1B $17.7B
 
Levered Free Cash Flow $4.1B $3.9B $3.3B $5.1B $6.4B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $13.1B $15.2B $18B $20B $20.8B
Depreciation & Amoritzation $805M $890M $963M $1.1B $1.3B
Stock-Based Compensation $548M $651M $797M $865M $904M
Change in Accounts Receivable -$748M -$319M -$748M -$1.4B $111M
Change in Inventories -- -- -- -- --
Cash From Operations $15.9B $18.8B $20.2B $21.7B $24.4B
 
Capital Expenditures $718M $1B $1.1B $1.3B $1.5B
Cash Acquisitions $832M $1.1B -- $1.8B -$19M
Cash From Investing -$1.3B -$4.3B -$3.4B $753M $279M
 
Dividends Paid (Ex Special Dividend) $2.9B $3.3B $3.9B $4.3B $4.8B
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -$3.3B -- -- --
Repurchase of Common Stock $11B $10.6B $12.6B $17.1B $18B
Other Financing Activities -- -- $208M -$616M --
Cash From Financing -$13.8B -$14.1B -$15.8B -$21.7B -$22.5B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $268M $60M $1.3B $330M $3.2B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $15.2B $17.7B $19.1B $20.4B $22.9B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $4B $4.2B $4.9B $5.1B $5.9B
Depreciation & Amoritzation $198M $227M $247M $282M $326M
Stock-Based Compensation $128M $177M $209M $224M $231M
Change in Accounts Receivable -$289M -$114M -$452M $593M $872M
Change in Inventories -- -- -- -- --
Cash From Operations $4.2B $4.2B $3.6B $5.4B $6.8B
 
Capital Expenditures $173M $249M $267M $345M $378M
Cash Acquisitions $832M -- -- $906M --
Cash From Investing -$547M -$510M -$1.9B $790M $361M
 
Dividends Paid (Ex Special Dividend) $809M $945M $1.1B $1.2B $1.3B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -$2.3B -- -- --
Repurchase of Common Stock $4.1B $3.1B $3.6B $4B $3.7B
Other Financing Activities -- $19M $157M -$421M --
Cash From Financing -$5B -$6.3B -$4.4B -$5.5B -$9B
 
Beginning Cash (CF) $16B $15.8B $16.5B $16.4B $19.5B
Foreign Exchange Rate Adjustment -$194M $692M $300M -$508M $34M
Additions / Reductions -$1.5B -$2B -$2.4B $203M -$1.8B
Ending Cash (CF) $14.4B $14.5B $14.4B $16.1B $17.7B
 
Levered Free Cash Flow $4.1B $3.9B $3.3B $5.1B $6.4B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock